Requests that the FDA to determine whether a listed drug was withdrawn from sale for reasons of safety or effectiveness. | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-P-2524

Requests that the FDA to determine whether a listed drug was withdrawn from sale for reasons of safety or effectiveness.

Documents

Comments

Description

CLOSED

Key Dates

Comment Period OpensJul 21, 2025

Documents

Type	Title	Posted	Comments	Status
Other	Response Letter from FDA CDER to Novitium Pharma, LLC	Apr 14, 2026	--

Keywords

CDER

Citizen Petition

Novitium Pharma LLC

determine whether a listed drug was withdrawn

from sale for reasons of safety or effectiveness

CLOSED

Data from Regulations.gov